Red Spruce Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Hold |
504
| – | – | 0.09% | 90 |
|
|
2025
Q1 | $251K | Sell |
504
-1,333
| -73% | -$663K | 0.12% | 84 |
|
|
2024
Q4 | $956K | Buy |
1,837
+311
| +20% | +$162K | 0.42% | 66 |
|
|
2024
Q3 | $944K | Hold |
1,526
| – | – | 0.43% | 66 |
|
|
2024
Q2 | $844K | Buy |
1,526
+75
| +5% | +$41.5K | 0.39% | 69 |
|
|
2024
Q1 | $843K | Buy |
1,451
+21
| +1% | +$12.2K | 0.39% | 69 |
|
|
2023
Q4 | $759K | Buy |
1,430
+31
| +2% | +$16.5K | 0.39% | 69 |
|
|
2023
Q3 | $708K | Buy |
1,399
+8
| +0.6% | +$4.05K | 0.4% | 66 |
|
|
2023
Q2 | $726K | Buy |
1,391
+112
| +9% | +$58.4K | 0.39% | 70 |
|
|
2023
Q1 | $737K | Buy |
1,279
+16
| +1% | +$9.22K | 0.43% | 68 |
|
|
2022
Q4 | $696K | Hold |
1,263
| – | – | 0.44% | 63 |
|
|
2022
Q3 | $641K | Buy |
1,263
+37
| +3% | +$18.8K | 0.45% | 63 |
|
|
2022
Q2 | $666K | Sell |
1,226
-23
| -2% | -$12.5K | 0.44% | 66 |
|
|
2022
Q1 | $738K | Buy |
1,249
+179
| +17% | +$106K | 0.42% | 70 |
|
|
2021
Q4 | $714K | Hold |
1,070
| – | – | 0.39% | 75 |
|
|
2021
Q3 | $611K | Buy |
1,070
+13
| +1% | +$7.42K | 0.36% | 77 |
|
|
2021
Q2 | $533K | Buy |
1,057
+19
| +2% | +$9.58K | 0.31% | 81 |
|
|
2021
Q1 | $474K | Buy |
1,038
+45
| +5% | +$20.5K | 0.3% | 80 |
|
|
2020
Q4 | $463K | Buy |
993
+79
| +9% | +$36.8K | 0.32% | 79 |
|
|
2020
Q3 | $404K | Hold |
914
| – | – | 0.33% | 75 |
|
|
2020
Q2 | $331K | Buy |
914
+20
| +2% | +$7.24K | 0.28% | 77 |
|
|
2020
Q1 | $254K | Buy |
+894
| New | +$254K | 0.26% | 77 |
|